(Q36984511)

English

The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials

scientific article published on 15 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials (English)

1 reference

Europe PubMed Central

17 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Richard J Sylvester

1

1 reference

Europe PubMed Central

17 August 2017

Willem Oosterlinck

2

1 reference

Europe PubMed Central

17 August 2017

J Alfred Witjes

3

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

15 January 2008

1 reference

Europe PubMed Central

17 August 2017

European Urology

1 reference

Europe PubMed Central

17 August 2017

53

1 reference

Europe PubMed Central

17 August 2017

709-719

1 reference

Europe PubMed Central

17 August 2017

4

1 reference

Europe PubMed Central

17 August 2017

A second-look TUR in T1 transitional cell carcinoma: why?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

29 September 2017

Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer geni

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

29 September 2017

Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

29 September 2017

Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

27 June 2018

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

27 June 2018

Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

27 June 2018

Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587437

4 September 2018

Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Wor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instill

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemotherapy with epirubicin: a dose response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EURURO.2008.01.015

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36984511&oldid=1743719072"